Release Date: 20/07/18 16:22 Summary: Announcement on Compulsory Acquisition-on behalf of Offeror Price Sensitive: Yes Download Document 332.8KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%